These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 20855461)

  • 1. Orally administered particulate beta-glucan modulates tumor-capturing dendritic cells and improves antitumor T-cell responses in cancer.
    Li B; Cai Y; Qi C; Hansen R; Ding C; Mitchell TC; Yan J
    Clin Cancer Res; 2010 Nov; 16(21):5153-64. PubMed ID: 20855461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential pathways regulating innate and adaptive antitumor immune responses by particulate and soluble yeast-derived β-glucans.
    Qi C; Cai Y; Gunn L; Ding C; Li B; Kloecker G; Qian K; Vasilakos J; Saijo S; Iwakura Y; Yannelli JR; Yan J
    Blood; 2011 Jun; 117(25):6825-36. PubMed ID: 21531981
    [TBL] [Abstract][Full Text] [Related]  

  • 3. β-glucan from Aureobasidium pullulans augments the anti-tumor immune responses through activated tumor-associated dendritic cells.
    Shui Y; Hu X; Hirano H; Kusano K; Tsukamoto H; Li M; Hasumi K; Guo WZ; Li XK
    Int Immunopharmacol; 2021 Dec; 101(Pt A):108265. PubMed ID: 34715491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. β-Glucan enhances antitumor immune responses by regulating differentiation and function of monocytic myeloid-derived suppressor cells.
    Tian J; Ma J; Ma K; Guo H; Baidoo SE; Zhang Y; Yan J; Lu L; Xu H; Wang S
    Eur J Immunol; 2013 May; 43(5):1220-30. PubMed ID: 23424024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Up-regulation of GITRL on dendritic cells by WGP improves anti-tumor immunity in murine Lewis lung carcinoma.
    Tian J; Ma J; Ma K; Ma B; Tang X; Baidoo SE; Tong J; Yan J; Lu L; Xu H; Wang S
    PLoS One; 2012; 7(10):e46936. PubMed ID: 23077535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism by which orally administered beta-1,3-glucans enhance the tumoricidal activity of antitumor monoclonal antibodies in murine tumor models.
    Hong F; Yan J; Baran JT; Allendorf DJ; Hansen RD; Ostroff GR; Xing PX; Cheung NK; Ross GD
    J Immunol; 2004 Jul; 173(2):797-806. PubMed ID: 15240666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble β-glucan from Grifola frondosa induces tumor regression in synergy with TLR9 agonist via dendritic cell-mediated immunity.
    Masuda Y; Nawa D; Nakayama Y; Konishi M; Nanba H
    J Leukoc Biol; 2015 Dec; 98(6):1015-25. PubMed ID: 26297795
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of Lewis lung carcinoma by photodynamic therapy and glucan from barley.
    Akramiene D; Grazeliene G; Didziapetriene J; Kevelaitis E
    Medicina (Kaunas); 2009; 45(6):480-5. PubMed ID: 19605969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Yeast beta-glucan amplifies phagocyte killing of iC3b-opsonized tumor cells via complement receptor 3-Syk-phosphatidylinositol 3-kinase pathway.
    Li B; Allendorf DJ; Hansen R; Marroquin J; Ding C; Cramer DE; Yan J
    J Immunol; 2006 Aug; 177(3):1661-9. PubMed ID: 16849475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. β-Glucan induces autophagy in dendritic cells and influences T-cell differentiation.
    Ding J; Ning Y; Bai Y; Xu X; Sun X; Qi C
    Med Microbiol Immunol; 2019 Feb; 208(1):39-48. PubMed ID: 30088084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of β-glucans on dendritic cells and implications for cancer therapy.
    Albeituni SH; Yan J
    Anticancer Agents Med Chem; 2013 Jun; 13(5):689-98. PubMed ID: 23092290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. β-glucan restores tumor-educated dendritic cell maturation to enhance antitumor immune responses.
    Ning Y; Xu D; Zhang X; Bai Y; Ding J; Feng T; Wang S; Xu N; Qian K; Wang Y; Qi C
    Int J Cancer; 2016 Jun; 138(11):2713-23. PubMed ID: 26773960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral administration of soluble β-glucans extracted from Grifola frondosa induces systemic antitumor immune response and decreases immunosuppression in tumor-bearing mice.
    Masuda Y; Inoue H; Ohta H; Miyake A; Konishi M; Nanba H
    Int J Cancer; 2013 Jul; 133(1):108-19. PubMed ID: 23280601
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic potential of various beta-glucan sources in conjunction with anti-tumor monoclonal antibody in cancer therapy.
    Driscoll M; Hansen R; Ding C; Cramer DE; Yan J
    Cancer Biol Ther; 2009 Feb; 8(3):218-25. PubMed ID: 19106638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The TLR-7 agonist, imiquimod, enhances dendritic cell survival and promotes tumor antigen-specific T cell priming: relation to central nervous system antitumor immunity.
    Prins RM; Craft N; Bruhn KW; Khan-Farooqi H; Koya RC; Stripecke R; Miller JF; Liau LM
    J Immunol; 2006 Jan; 176(1):157-64. PubMed ID: 16365406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta-glucan functions as an adjuvant for monoclonal antibody immunotherapy by recruiting tumoricidal granulocytes as killer cells.
    Hong F; Hansen RD; Yan J; Allendorf DJ; Baran JT; Ostroff GR; Ross GD
    Cancer Res; 2003 Dec; 63(24):9023-31. PubMed ID: 14695221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Consumption of β-glucans to spice up T cell treatment of tumors: a review.
    de Graaff P; Govers C; Wichers HJ; Debets R
    Expert Opin Biol Ther; 2018 Oct; 18(10):1023-1040. PubMed ID: 30221551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased expression of mGITRL on D2SC/1 cells by particulate β-glucan impairs the suppressive effect of CD4+CD25+ regulatory T cells and enhances the effector T cell proliferation.
    Tian J; Ma J; Wang S; Yan J; Chen J; Tong J; Wu C; Liu Y; Ma B; Mao C; Jiao Z; Shao Q; Lu L; Xu H
    Cell Immunol; 2011; 270(2):183-7. PubMed ID: 21636079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased numbers of monocyte-derived dendritic cells during successful tumor immunotherapy with immune-activating agents.
    Kuhn S; Hyde EJ; Yang J; Rich FJ; Harper JL; Kirman JR; Ronchese F
    J Immunol; 2013 Aug; 191(4):1984-92. PubMed ID: 23858033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral beta-glucan adjuvant therapy converts nonprotective Th2 response to protective Th1 cell-mediated immune response in mammary tumor-bearing mice.
    Baran J; Allendorf DJ; Hong F; Ross GD
    Folia Histochem Cytobiol; 2007; 45(2):107-14. PubMed ID: 17597024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.